Cytoplasmic PPARγ is a marker of poor prognosis in patients with Cox-1 negative primary breast cancers

BACKGROUND: The aim of this study was to investigate the expression of the nuclear receptor PPARγ, together with that of the cyclooxygenases Cox-1 and Cox-2, in breast cancer (BC) tissues and to correlate the data with several clinicobiological parameters including patient survival. METHODS: In a we...

Descripción completa

Detalles Bibliográficos
Autores principales: Shao, Wanting, Kuhn, Christina, Mayr, Doris, Ditsch, Nina, Kailuwait, Magdalena, Wolf, Verena, Harbeck, Nadia, Mahner, Sven, Jeschke, Udo, Cavaillès, Vincent, Sixou, Sophie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7035771/
https://www.ncbi.nlm.nih.gov/pubmed/32085795
http://dx.doi.org/10.1186/s12967-020-02271-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7035771/
https://www.ncbi.nlm.nih.gov/pubmed/32085795
http://dx.doi.org/10.1186/s12967-020-02271-6

Ejemplares similares